Evogene Ltd. (EVGN) vs Mustang Bio, Inc. (MBIO)
A side-by-side comparison of Evogene Ltd. and Mustang Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EVGN
Evogene Ltd.
$0.42HealthcareDelayed quote: Oct 6, 2026, 3:39 PM EDT
MBIO
Mustang Bio, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 3:38 PM EDT
Total return — EVGN vs MBIO
growth of $100 · dividends reinvested · last 9yEVGN -99.1% (-40.9%/yr)MBIO -100.0% (-65.9%/yr)EVGN compounded faster over this window
Log scale — wide-divergence pair
EVGN MBIO
EVGN vs MBIO: by the numbers
- •EVGN is the larger company ($4M vs $3M market cap).
- •Both run net losses; MBIO's is the smaller (0.00% vs -694.19% net margin).
Metrics side by side
Valuation
| Metric | EVGN | MBIO |
|---|---|---|
| P/S ratio | 2.77 | N/A |
| P/B ratio | N/A | 0.46 |
Profitability
| Metric | EVGN | MBIO |
|---|---|---|
| Gross margin | -6.25% | 0.00% |
| Operating margin | -364.24% | 0.00% |
| Net margin | -694.19% | 0.00% |
| ROE | N/A | -40.20% |
| ROIC | -130.12% | -45.77% |
Growth (annualized)
| Metric | EVGN | MBIO |
|---|---|---|
| Revenue CAGR (5Y) | 2.86% | N/A |
| Total return CAGR (5Y) | -56.46% | -80.80% |
Frequently asked
- How have EVGN and MBIO total returns compared?
- Over the past 5 years, EVGN delivered -56.46% and MBIO delivered -80.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.